Filed before 2025Filed 17 August 2016
Cleave Biosciences, Inc. raised $26M
Cleave Biosciences, Inc., a biotech company based in Burlingame, CA, raised $26M in a new equity round, according to a filing dated 17 August 2016.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 17 August 2016
- Round
- Equity round
- Amount sold
- $26M
- Offering size
- $36.8M
- Investors so far
- 13
- Based in
- Burlingame, CA
Investors on the board
- U.S. Venture
- 5AM Ventures
- Excelerate Health Ventures
- Nextech Crossover
- Nextech VII Oncology
- Nextech VII Carry
- Clarus Lifesciences
- Clarus Ventures
- Clarus DE
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
4 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 88% of the 1,506 tracked raises with an amount filed in 2016, and than 82% of the 120 in biotech.
Cleave Biosciences, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 18 Jun 2019 | New filing | $12M | Another raise |
| 17 Aug 2016 | New filing | $26M | This raise |
More with U.S. Venture on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.